APO Research

APO RESEARCH · REPORT

Immunology-Oncology Elisa Kits

Selected research

Market Analysis & Forecast

Global Immunology-Oncology Elisa Kits Market Analysis and Forecast 2026-2032

Market perspective

The global Immunology-Oncology Elisa Kits market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Immunology-Oncology Elisa Kits is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Immunology-Oncology Elisa Kits is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Immunology-Oncology Elisa Kits is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Immunology-Oncology Elisa Kits is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Immunology-Oncology Elisa Kits include Thermo Fisher Scientific, MilliporeSigma (Merck KGaA), RayBiotech Life, Inc., Enzo Life Sciences, ELISAGEN Biotech, Creative Diagnostics, Bio-Techne Corporation (R&D Systems), BioLegend (part of PerkinElmer) and BD Biosciences, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Immunology-Oncology Elisa Kits, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Immunology-Oncology Elisa Kits, also provides the sales of main regions and countries. Of the upcoming market potential for Immunology-Oncology Elisa Kits, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Immunology-Oncology Elisa Kits sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Immunology-Oncology Elisa Kits market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Immunology-Oncology Elisa Kits sales, projected growth trends, production technology, application and end-user industry.

Immunology-Oncology Elisa Kits Segment by Company

Thermo Fisher Scientific

MilliporeSigma (Merck KGaA)

RayBiotech Life, Inc.

Enzo Life Sciences

ELISAGEN Biotech

Creative Diagnostics

Bio-Techne Corporation (R&D Systems)

BioLegend (part of PerkinElmer)

BD Biosciences

Abcam

Immunology-Oncology Elisa Kits Segment by Type

Direct ELISA Kit

Indirect ELISA Kit

Immunology-Oncology Elisa Kits Segment by Application

Cancer Diagnosis

Pharmaceutical Industry

Other

Immunology-Oncology Elisa Kits Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immunology-Oncology Elisa Kits market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immunology-Oncology Elisa Kits and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immunology-Oncology Elisa Kits.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Immunology-Oncology Elisa Kits in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Immunology-Oncology Elisa Kits manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immunology-Oncology Elisa Kits sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Immunology-Oncology Elisa Kits Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Direct ELISA Kit Major Manufacturers Table 3. Indirect ELISA Kit Major Manufacturers Table 4. Global Immunology-Oncology Elisa Kits Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Cancer Diagnosis Major Manufacturers Table 6. Pharmaceutical Industry Major Manufacturers Table 7. Other Major Manufacturers Table 8. Immunology-Oncology Elisa Kits Industry Trends Table 9. Immunology-Oncology Elisa Kits Industry Drivers Table 10. Immunology-Oncology Elisa Kits Industry Opportunities and Challenges Table 11. Immunology-Oncology Elisa Kits Industry Restraints Table 12. Global Immunology-Oncology Elisa Kits Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Immunology-Oncology Elisa Kits Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Immunology-Oncology Elisa Kits Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Immunology-Oncology Elisa Kits Revenue Market Share by Region (2021-2026) Table 16. Global Immunology-Oncology Elisa Kits Revenue Market Share by Region (2027-2032) Table 17. Global Immunology-Oncology Elisa Kits Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Immunology-Oncology Elisa Kits Sales by Region (2021-2026) & (K Units) Table 19. Global Immunology-Oncology Elisa Kits Sales by Region (2027-2032) & (K Units) Table 20. Global Immunology-Oncology Elisa Kits Sales Market Share by Region (2021-2026) Table 21. Global Immunology-Oncology Elisa Kits Sales Market Share by Region (2027-2032) Table 22. Global Immunology-Oncology Elisa Kits Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Immunology-Oncology Elisa Kits Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Immunology-Oncology Elisa Kits Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Immunology-Oncology Elisa Kits Sales Market Share by Manufacturers (2021-2026) Table 26. Global Immunology-Oncology Elisa Kits Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Immunology-Oncology Elisa Kits Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Immunology-Oncology Elisa Kits Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Immunology-Oncology Elisa Kits Manufacturers, Product Type & Application Table 30. Global Immunology-Oncology Elisa Kits Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Immunology-Oncology Elisa Kits by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Immunology-Oncology Elisa Kits Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Immunology-Oncology Elisa Kits Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Immunology-Oncology Elisa Kits Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Immunology-Oncology Elisa Kits Revenue Market Share by Type (2021-2026) Table 37. Global Immunology-Oncology Elisa Kits Revenue Market Share by Type (2027-2032) Table 38. Global Immunology-Oncology Elisa Kits Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Immunology-Oncology Elisa Kits Sales by Type (2021-2026) & (K Units) Table 40. Global Immunology-Oncology Elisa Kits Sales by Type (2027-2032) & (K Units) Table 41. Global Immunology-Oncology Elisa Kits Sales Market Share by Type (2021-2026) Table 42. Global Immunology-Oncology Elisa Kits Sales Market Share by Type (2027-2032) Table 43. Global Immunology-Oncology Elisa Kits Price by Type (2021-2026) & (US$/Unit) Table 44. Global Immunology-Oncology Elisa Kits Price by Type (2027-2032) & (US$/Unit) Table 45. Global Immunology-Oncology Elisa Kits Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Immunology-Oncology Elisa Kits Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Immunology-Oncology Elisa Kits Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Immunology-Oncology Elisa Kits Revenue Market Share by Application (2021-2026) Table 49. Global Immunology-Oncology Elisa Kits Revenue Market Share by Application (2027-2032) Table 50. Global Immunology-Oncology Elisa Kits Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Immunology-Oncology Elisa Kits Sales by Application (2021-2026) & (K Units) Table 52. Global Immunology-Oncology Elisa Kits Sales by Application (2027-2032) & (K Units) Table 53. Global Immunology-Oncology Elisa Kits Sales Market Share by Application (2021-2026) Table 54. Global Immunology-Oncology Elisa Kits Sales Market Share by Application (2027-2032) Table 55. Global Immunology-Oncology Elisa Kits Price by Application (2021-2026) & (US$/Unit) Table 56. Global Immunology-Oncology Elisa Kits Price by Application (2027-2032) & (US$/Unit) Table 57. Thermo Fisher Scientific Company Information Table 58. Thermo Fisher Scientific Business Overview Table 59. Thermo Fisher Scientific Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Thermo Fisher Scientific Immunology-Oncology Elisa Kits Product Portfolio Table 61. Thermo Fisher Scientific Recent Development Table 62. MilliporeSigma (Merck KGaA) Company Information Table 63. MilliporeSigma (Merck KGaA) Business Overview Table 64. MilliporeSigma (Merck KGaA) Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. MilliporeSigma (Merck KGaA) Immunology-Oncology Elisa Kits Product Portfolio Table 66. MilliporeSigma (Merck KGaA) Recent Development Table 67. RayBiotech Life, Inc. Company Information Table 68. RayBiotech Life, Inc. Business Overview Table 69. RayBiotech Life, Inc. Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. RayBiotech Life, Inc. Immunology-Oncology Elisa Kits Product Portfolio Table 71. RayBiotech Life, Inc. Recent Development Table 72. Enzo Life Sciences Company Information Table 73. Enzo Life Sciences Business Overview Table 74. Enzo Life Sciences Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Enzo Life Sciences Immunology-Oncology Elisa Kits Product Portfolio Table 76. Enzo Life Sciences Recent Development Table 77. ELISAGEN Biotech Company Information Table 78. ELISAGEN Biotech Business Overview Table 79. ELISAGEN Biotech Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. ELISAGEN Biotech Immunology-Oncology Elisa Kits Product Portfolio Table 81. ELISAGEN Biotech Recent Development Table 82. Creative Diagnostics Company Information Table 83. Creative Diagnostics Business Overview Table 84. Creative Diagnostics Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Creative Diagnostics Immunology-Oncology Elisa Kits Product Portfolio Table 86. Creative Diagnostics Recent Development Table 87. Bio-Techne Corporation (R&D Systems) Company Information Table 88. Bio-Techne Corporation (R&D Systems) Business Overview Table 89. Bio-Techne Corporation (R&D Systems) Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Bio-Techne Corporation (R&D Systems) Immunology-Oncology Elisa Kits Product Portfolio Table 91. Bio-Techne Corporation (R&D Systems) Recent Development Table 92. BioLegend (part of PerkinElmer) Company Information Table 93. BioLegend (part of PerkinElmer) Business Overview Table 94. BioLegend (part of PerkinElmer) Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. BioLegend (part of PerkinElmer) Immunology-Oncology Elisa Kits Product Portfolio Table 96. BioLegend (part of PerkinElmer) Recent Development Table 97. BD Biosciences Company Information Table 98. BD Biosciences Business Overview Table 99. BD Biosciences Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. BD Biosciences Immunology-Oncology Elisa Kits Product Portfolio Table 101. BD Biosciences Recent Development Table 102. Abcam Company Information Table 103. Abcam Business Overview Table 104. Abcam Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Abcam Immunology-Oncology Elisa Kits Product Portfolio Table 106. Abcam Recent Development Table 107. North America Immunology-Oncology Elisa Kits Revenue by Type (2021-2026) & (US$ Million) Table 108. North America Immunology-Oncology Elisa Kits Revenue by Type (2027-2032) & (US$ Million) Table 109. North America Immunology-Oncology Elisa Kits Sales by Type (2021-2026) & (K Units) Table 110. North America Immunology-Oncology Elisa Kits Sales by Type (2027-2032) & (K Units) Table 111. North America Immunology-Oncology Elisa Kits Sales Price by Type (2021-2026) & (US$/Unit) Table 112. North America Immunology-Oncology Elisa Kits Sales Price by Type (2027-2032) & (US$/Unit) Table 113. North America Immunology-Oncology Elisa Kits Revenue by Application (2021-2026) & (US$ Million) Table 114. North America Immunology-Oncology Elisa Kits Revenue by Application (2027-2032) & (US$ Million) Table 115. North America Immunology-Oncology Elisa Kits Sales by Application (2021-2026) & (K Units) Table 116. North America Immunology-Oncology Elisa Kits Sales by Application (2027-2032) & (K Units) Table 117. North America Immunology-Oncology Elisa Kits Sales Price by Application (2021-2026) & (US$/Unit) Table 118. North America Immunology-Oncology Elisa Kits Sales Price by Application (2027-2032) & (US$/Unit) Table 119. North America Immunology-Oncology Elisa Kits Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. North America Immunology-Oncology Elisa Kits Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 121. North America Immunology-Oncology Elisa Kits Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 122. North America Immunology-Oncology Elisa Kits Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 123. North America Immunology-Oncology Elisa Kits Sales by Country (2021-2026) & (K Units) Table 124. North America Immunology-Oncology Elisa Kits Sales by Country (2027-2032) & (K Units) Table 125. North America Immunology-Oncology Elisa Kits Sales Price by Country (2021-2026) & (US$/Unit) Table 126. North America Immunology-Oncology Elisa Kits Sales Price by Country (2027-2032) & (US$/Unit) Table 127. United States Immunology-Oncology Elisa Kits Revenue (2021-2032) & (US$ Million) Table 128. Canada Immunology-Oncology Elisa Kits Revenue (2021-2032) & (US$ Million) Table 129. Mexico Immunology-Oncology Elisa Kits Revenue (2021-2032) & (US$ Million) Table 130. Europe Immunology-Oncology Elisa Kits Revenue by Type (2021-2026) & (US$ Million) Table 131. Europe Immunology-Oncology Elisa Kits Revenue by Type (2027-2032) & (US$ Million) Table 132. Europe Immunology-Oncology Elisa Kits Sales by Type (2021-2026) & (K Units) Table 133. Europe Immunology-Oncology Elisa Kits Sales by Type (2027-2032) & (K Units) Table 134. Europe Immunology-Oncology Elisa Kits Sales Price by Type (2021-2026) & (US$/Unit) Table 135. Europe Immunology-Oncology Elisa Kits Sales Price by Type (2027-2032) & (US$/Unit) Table 136. Europe Immunology-Oncology Elisa Kits Revenue by Application (2021-2026) & (US$ Million) Table 137. Europe Immunology-Oncology Elisa Kits Revenue by Application (2027-2032) & (US$ Million) Table 138. Europe Immunology-Oncology Elisa Kits Sales by Application (2021-2026) & (K Units) Table 139. Europe Immunology-Oncology Elisa Kits Sales by Application (2027-2032) & (K Units) Table 140. Europe Immunology-Oncology Elisa Kits Sales Price by Application (2021-2026) & (US$/Unit) Table 141. Europe Immunology-Oncology Elisa Kits Sales Price by Application (2027-2032) & (US$/Unit) Table 142. Europe Immunology-Oncology Elisa Kits Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. Europe Immunology-Oncology Elisa Kits Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 144. Europe Immunology-Oncology Elisa Kits Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 145. Europe Immunology-Oncology Elisa Kits Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 146. Europe Immunology-Oncology Elisa Kits Sales by Country (2021-2026) & (K Units) Table 147. Europe Immunology-Oncology Elisa Kits Sales by Country (2027-2032) & (K Units) Table 148. Europe Immunology-Oncology Elisa Kits Sales Price by Country (2021-2026) & (US$/Unit) Table 149. Europe Immunology-Oncology Elisa Kits Sales Price by Country (2027-2032) & (US$/Unit) Table 150. Germany Immunology-Oncology Elisa Kits Revenue (2021-2032) & (US$ Million) Table 151. France Immunology-Oncology Elisa Kits Revenue (2021-2032) & (US$ Million) Table 152. U.K. Immunology-Oncology Elisa Kits Revenue (2021-2032) & (US$ Million) Table 153. Italy Immunology-Oncology Elisa Kits Revenue (2021-2032) & (US$ Million) Table 154. Russia Immunology-Oncology Elisa Kits Revenue (2021-2032) & (US$ Million) Table 155. Spain Immunology-Oncology Elisa Kits Revenue (2021-2032) & (US$ Million) Table 156. Netherlands Immunology-Oncology Elisa Kits Revenue (2021-2032) & (US$ Million) Table 157. Switzerland Immunology-Oncology Elisa Kits Revenue (2021-2032) & (US$ Million) Table 158. Sweden Immunology-Oncology Elisa Kits Revenue (2021-2032) & (US$ Million) Table 159. Poland Immunology-Oncology Elisa Kits Revenue (2021-2032) & (US$ Million) Table 160. China Immunology-Oncology Elisa Kits Revenue by Type (2021-2026) & (US$ Million) Table 161. China Immunology-Oncology Elisa Kits Revenue by Type (2027-2032) & (US$ Million) Table 162. China Immunology-Oncology Elisa Kits Sales by Type (2021-2026) & (K Units) Table 163. China Immunology-Oncology Elisa Kits Sales by Type (2027-2032) & (K Units) Table 164. China Immunology-Oncology Elisa Kits Sales Price by Type (2021-2026) & (US$/Unit) Table 165. China Immunology-Oncology Elisa Kits Sales Price by Type (2027-2032) & (US$/Unit) Table 166. China Immunology-Oncology Elisa Kits Revenue by Application (2021-2026) & (US$ Million) Table 167. China Immunology-Oncology Elisa Kits Revenue by Application (2027-2032) & (US$ Million) Table 168. China Immunology-Oncology Elisa Kits Sales by Application (2021-2026) & (K Units) Table 169. China Immunology-Oncology Elisa Kits Sales by Application (2027-2032) & (K Units) Table 170. China Immunology-Oncology Elisa Kits Sales Price by Application (2021-2026) & (US$/Unit) Table 171. China Immunology-Oncology Elisa Kits Sales Price by Application (2027-2032) & (US$/Unit) Table 172. Asia Immunology-Oncology Elisa Kits Revenue by Type (2021-2026) & (US$ Million) Table 173. Asia Immunology-Oncology Elisa Kits Revenue by Type (2027-2032) & (US$ Million) Table 174. Asia Immunology-Oncology Elisa Kits Sales by Type (2021-2026) & (K Units) Table 175. Asia Immunology-Oncology Elisa Kits Sales by Type (2027-2032) & (K Units) Table 176. Asia Immunology-Oncology Elisa Kits Sales Price by Type (2021-2026) & (US$/Unit) Table 177. Asia Immunology-Oncology Elisa Kits Sales Price by Type (2027-2032) & (US$/Unit) Table 178. Asia Immunology-Oncology Elisa Kits Revenue by Application (2021-2026) & (US$ Million) Table 179. Asia Immunology-Oncology Elisa Kits Revenue by Application (2027-2032) & (US$ Million) Table 180. Asia Immunology-Oncology Elisa Kits Sales by Application (2021-2026) & (K Units) Table 181. Asia Immunology-Oncology Elisa Kits Sales by Application (2027-2032) & (K Units) Table 182. Asia Immunology-Oncology Elisa Kits Sales Price by Application (2021-2026) & (US$/Unit) Table 183. Asia Immunology-Oncology Elisa Kits Sales Price by Application (2027-2032) & (US$/Unit) Table 184. Asia Immunology-Oncology Elisa Kits Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. Asia Immunology-Oncology Elisa Kits Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. Asia Immunology-Oncology Elisa Kits Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. Asia Immunology-Oncology Elisa Kits Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 188. Asia Immunology-Oncology Elisa Kits Sales by Country (2021-2026) & (K Units) Table 189. Asia Immunology-Oncology Elisa Kits Sales by Country (2027-2032) & (K Units) Table 190. Asia Immunology-Oncology Elisa Kits Sales Price by Country (2021-2026) & (US$/Unit) Table 191. Asia Immunology-Oncology Elisa Kits Sales Price by Country (2027-2032) & (US$/Unit) Table 192. Japan Immunology-Oncology Elisa Kits Revenue (2021-2032) & (US$ Million) Table 193. South Korea Immunology-Oncology Elisa Kits Revenue (2021-2032) & (US$ Million) Table 194. India Immunology-Oncology Elisa Kits Revenue (2021-2032) & (US$ Million) Table 195. Australia Immunology-Oncology Elisa Kits Revenue (2021-2032) & (US$ Million) Table 196. Taiwan Immunology-Oncology Elisa Kits Revenue (2021-2032) & (US$ Million) Table 197. Southeast Asia Immunology-Oncology Elisa Kits Revenue (2021-2032) & (US$ Million) Table 198. SAMEA Immunology-Oncology Elisa Kits Revenue by Type (2021-2026) & (US$ Million) Table 199. SAMEA Immunology-Oncology Elisa Kits Revenue by Type (2027-2032) & (US$ Million) Table 200. SAMEA Immunology-Oncology Elisa Kits Sales by Type (2021-2026) & (K Units) Table 201. SAMEA Immunology-Oncology Elisa Kits Sales by Type (2027-2032) & (K Units) Table 202. SAMEA Immunology-Oncology Elisa Kits Sales Price by Type (2021-2026) & (US$/Unit) Table 203. SAMEA Immunology-Oncology Elisa Kits Sales Price by Type (2027-2032) & (US$/Unit) Table 204. SAMEA Immunology-Oncology Elisa Kits Revenue by Application (2021-2026) & (US$ Million) Table 205. SAMEA Immunology-Oncology Elisa Kits Revenue by Application (2027-2032) & (US$ Million) Table 206. SAMEA Immunology-Oncology Elisa Kits Sales by Application (2021-2026) & (K Units) Table 207. SAMEA Immunology-Oncology Elisa Kits Sales by Application (2027-2032) & (K Units) Table 208. SAMEA Immunology-Oncology Elisa Kits Sales Price by Application (2021-2026) & (US$/Unit) Table 209. SAMEA Immunology-Oncology Elisa Kits Sales Price by Application (2027-2032) & (US$/Unit) Table 210. SAMEA Immunology-Oncology Elisa Kits Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 211. SAMEA Immunology-Oncology Elisa Kits Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 212. SAMEA Immunology-Oncology Elisa Kits Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 213. SAMEA Immunology-Oncology Elisa Kits Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 214. SAMEA Immunology-Oncology Elisa Kits Sales by Country (2021-2026) & (K Units) Table 215. SAMEA Immunology-Oncology Elisa Kits Sales by Country (2027-2032) & (K Units) Table 216. SAMEA Immunology-Oncology Elisa Kits Sales Price by Country (2021-2026) & (US$/Unit) Table 217. SAMEA Immunology-Oncology Elisa Kits Sales Price by Country (2027-2032) & (US$/Unit) Table 218. Brazil Immunology-Oncology Elisa Kits Revenue (2021-2032) & (US$ Million) Table 219. Argentina Immunology-Oncology Elisa Kits Revenue (2021-2032) & (US$ Million) Table 220. Chile Immunology-Oncology Elisa Kits Revenue (2021-2032) & (US$ Million) Table 221. Colombia Immunology-Oncology Elisa Kits Revenue (2021-2032) & (US$ Million) Table 222. Peru Immunology-Oncology Elisa Kits Revenue (2021-2032) & (US$ Million) Table 223. Saudi Arabia Immunology-Oncology Elisa Kits Revenue (2021-2032) & (US$ Million) Table 224. Israel Immunology-Oncology Elisa Kits Revenue (2021-2032) & (US$ Million) Table 225. UAE Immunology-Oncology Elisa Kits Revenue (2021-2032) & (US$ Million) Table 226. Turkey Immunology-Oncology Elisa Kits Revenue (2021-2032) & (US$ Million) Table 227. Iran Immunology-Oncology Elisa Kits Revenue (2021-2032) & (US$ Million) Table 228. Egypt Immunology-Oncology Elisa Kits Revenue (2021-2032) & (US$ Million) Table 229. Key Raw Materials Table 230. Raw Materials Key Suppliers Table 231. Immunology-Oncology Elisa Kits Distributors List Table 232. Immunology-Oncology Elisa Kits Customers List Table 233. Research Programs/Design for This Report Table 234. Authors List of This Report Table 235. Secondary Sources Table 236. Primary Sources List of Figures Figure 1. Immunology-Oncology Elisa Kits Image Figure 2. Global Immunology-Oncology Elisa Kits Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Immunology-Oncology Elisa Kits Market Size Share 2021 VS 2025 VS 2032 Figure 4. Direct ELISA Kit Image Figure 5. Indirect ELISA Kit Image Figure 6. Global Immunology-Oncology Elisa Kits Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Immunology-Oncology Elisa Kits Market Size Share 2021 VS 2025 VS 2032 Figure 8. Cancer Diagnosis Image Figure 9. Pharmaceutical Industry Image Figure 10. Other Image Figure 11. Global Immunology-Oncology Elisa Kits Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Immunology-Oncology Elisa Kits Revenue (2021-2032) & (US$ Million) Figure 13. Global Immunology-Oncology Elisa Kits Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Immunology-Oncology Elisa Kits Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Immunology-Oncology Elisa Kits Revenue Market Share by Region (2021-2032) Figure 16. Global Immunology-Oncology Elisa Kits Sales (2021-2032) & (K Units) Figure 17. Global Immunology-Oncology Elisa Kits Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Immunology-Oncology Elisa Kits Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Immunology-Oncology Elisa Kits Sales YoY (2021-2032) & (K Units) Figure 20. Europe Immunology-Oncology Elisa Kits Sales YoY (2021-2032) & (K Units) Figure 21. China Immunology-Oncology Elisa Kits Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Immunology-Oncology Elisa Kits Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Immunology-Oncology Elisa Kits Sales YoY (2021-2032) & (K Units) Figure 24. Global Immunology-Oncology Elisa Kits Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Immunology-Oncology Elisa Kits Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Immunology-Oncology Elisa Kits Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Immunology-Oncology Elisa Kits Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Immunology-Oncology Elisa Kits Revenue Market Share by Type (2021-2032) Figure 30. Global Immunology-Oncology Elisa Kits Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Immunology-Oncology Elisa Kits Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Immunology-Oncology Elisa Kits Sales Market Share by Type (2021-2032) Figure 33. Global Immunology-Oncology Elisa Kits Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Immunology-Oncology Elisa Kits Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Immunology-Oncology Elisa Kits Revenue Market Share by Application (2021-2032) Figure 36. Global Immunology-Oncology Elisa Kits Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Immunology-Oncology Elisa Kits Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Immunology-Oncology Elisa Kits Sales Market Share by Application (2021-2032) Figure 39. North America Immunology-Oncology Elisa Kits Revenue Share by Type (2021-2032) Figure 40. North America Immunology-Oncology Elisa Kits Sales Share by Type (2021-2032) Figure 41. North America Immunology-Oncology Elisa Kits Revenue Share by Application (2021-2032) Figure 42. North America Immunology-Oncology Elisa Kits Sales Share by Application (2021-2032) Figure 43. North America Immunology-Oncology Elisa Kits Revenue Share by Country (2021-2032) Figure 44. North America Immunology-Oncology Elisa Kits Sales Share by Country (2021-2032) Figure 45. Europe Immunology-Oncology Elisa Kits Revenue Share by Type (2021-2032) Figure 46. Europe Immunology-Oncology Elisa Kits Sales Share by Type (2021-2032) Figure 47. Europe Immunology-Oncology Elisa Kits Revenue Share by Application (2021-2032) Figure 48. Europe Immunology-Oncology Elisa Kits Sales Share by Application (2021-2032) Figure 49. Europe Immunology-Oncology Elisa Kits Revenue Share by Country (2021-2032) Figure 50. Europe Immunology-Oncology Elisa Kits Sales Share by Country (2021-2032) Figure 51. China Immunology-Oncology Elisa Kits Revenue Share by Type (2021-2032) Figure 52. China Immunology-Oncology Elisa Kits Sales Share by Type (2021-2032) Figure 53. China Immunology-Oncology Elisa Kits Revenue Share by Application (2021-2032) Figure 54. China Immunology-Oncology Elisa Kits Sales Share by Application (2021-2032) Figure 55. Asia Immunology-Oncology Elisa Kits Revenue Share by Type (2021-2032) Figure 56. Asia Immunology-Oncology Elisa Kits Sales Share by Type (2021-2032) Figure 57. Asia Immunology-Oncology Elisa Kits Revenue Share by Application (2021-2032) Figure 58. Asia Immunology-Oncology Elisa Kits Sales Share by Application (2021-2032) Figure 59. Asia Immunology-Oncology Elisa Kits Revenue Share by Country (2021-2032) Figure 60. Asia Immunology-Oncology Elisa Kits Sales Share by Country (2021-2032) Figure 61. SAMEA Immunology-Oncology Elisa Kits Revenue Share by Type (2021-2032) Figure 62. SAMEA Immunology-Oncology Elisa Kits Sales Share by Type (2021-2032) Figure 63. SAMEA Immunology-Oncology Elisa Kits Revenue Share by Application (2021-2032) Figure 64. SAMEA Immunology-Oncology Elisa Kits Sales Share by Application (2021-2032) Figure 65. SAMEA Immunology-Oncology Elisa Kits Revenue Share by Country (2021-2032) Figure 66. SAMEA Immunology-Oncology Elisa Kits Sales Share by Country (2021-2032) Figure 67. Immunology-Oncology Elisa Kits Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Immunology-Oncology Elisa Kits Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Direct ELISA Kit
  • Indirect ELISA Kit
Applications
  • Cancer Diagnosis
  • Pharmaceutical Industry
  • Other
Companies covered
  • Thermo Fisher Scientific
  • MilliporeSigma (Merck KGaA)
  • RayBiotech Life, Inc.
  • Enzo Life Sciences
  • ELISAGEN Biotech
  • Creative Diagnostics
  • Bio-Techne Corporation (R&D Systems)
  • BioLegend (part of PerkinElmer)
  • BD Biosciences
  • Abcam

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Immunology-Oncology Elisa Kits Market by Type
  3. 1.2.1 Global Immunology-Oncology Elisa Kits Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Direct ELISA Kit
  5. 1.2.3 Indirect ELISA Kit
  6. 1.3 Immunology-Oncology Elisa Kits Market by Application
  7. 1.3.1 Global Immunology-Oncology Elisa Kits Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Cancer Diagnosis
  9. 1.3.3 Pharmaceutical Industry
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Immunology-Oncology Elisa Kits Market Dynamics
  1. 2.1 Immunology-Oncology Elisa Kits Industry Trends
  2. 2.2 Immunology-Oncology Elisa Kits Industry Drivers
  3. 2.3 Immunology-Oncology Elisa Kits Industry Opportunities and Challenges
  4. 2.4 Immunology-Oncology Elisa Kits Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Immunology-Oncology Elisa Kits Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Immunology-Oncology Elisa Kits Revenue by Region
  3. 3.2.1 Global Immunology-Oncology Elisa Kits Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Immunology-Oncology Elisa Kits Revenue by Region (2021-2026)
  5. 3.2.3 Global Immunology-Oncology Elisa Kits Revenue by Region (2027-2032)
  6. 3.2.4 Global Immunology-Oncology Elisa Kits Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Immunology-Oncology Elisa Kits Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Immunology-Oncology Elisa Kits Sales by Region
  9. 3.4.1 Global Immunology-Oncology Elisa Kits Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Immunology-Oncology Elisa Kits Sales by Region (2021-2026)
  11. 3.4.3 Global Immunology-Oncology Elisa Kits Sales by Region (2027-2032)
  12. 3.4.4 Global Immunology-Oncology Elisa Kits Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Immunology-Oncology Elisa Kits Revenue by Manufacturers
  2. 4.1.1 Global Immunology-Oncology Elisa Kits Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Immunology-Oncology Elisa Kits Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Immunology-Oncology Elisa Kits Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Immunology-Oncology Elisa Kits Sales by Manufacturers
  6. 4.2.1 Global Immunology-Oncology Elisa Kits Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Immunology-Oncology Elisa Kits Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Immunology-Oncology Elisa Kits Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Immunology-Oncology Elisa Kits Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Immunology-Oncology Elisa Kits Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Immunology-Oncology Elisa Kits Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Immunology-Oncology Elisa Kits Manufacturers, Product Type & Application
  13. 4.7 Global Immunology-Oncology Elisa Kits Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Immunology-Oncology Elisa Kits Market CR5 and HHI
  16. 4.8.2 2025 Immunology-Oncology Elisa Kits Tier 1, Tier 2, and Tier 3
5 Immunology-Oncology Elisa Kits Market by Type
  1. 5.1 Global Immunology-Oncology Elisa Kits Revenue by Type
  2. 5.1.1 Global Immunology-Oncology Elisa Kits Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Immunology-Oncology Elisa Kits Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Immunology-Oncology Elisa Kits Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Immunology-Oncology Elisa Kits Sales by Type
  6. 5.2.1 Global Immunology-Oncology Elisa Kits Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Immunology-Oncology Elisa Kits Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Immunology-Oncology Elisa Kits Sales Market Share by Type (2021-2032)
  9. 5.3 Global Immunology-Oncology Elisa Kits Price by Type
6 Immunology-Oncology Elisa Kits Market by Application
  1. 6.1 Global Immunology-Oncology Elisa Kits Revenue by Application
  2. 6.1.1 Global Immunology-Oncology Elisa Kits Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Immunology-Oncology Elisa Kits Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Immunology-Oncology Elisa Kits Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Immunology-Oncology Elisa Kits Sales by Application
  6. 6.2.1 Global Immunology-Oncology Elisa Kits Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Immunology-Oncology Elisa Kits Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Immunology-Oncology Elisa Kits Sales Market Share by Application (2021-2032)
  9. 6.3 Global Immunology-Oncology Elisa Kits Price by Application
7 Company Profiles
  1. 7.1 Thermo Fisher Scientific
  2. 7.1.1 Thermo Fisher Scientific Company Information
  3. 7.1.2 Thermo Fisher Scientific Business Overview
  4. 7.1.3 Thermo Fisher Scientific Immunology-Oncology Elisa Kits Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Thermo Fisher Scientific Immunology-Oncology Elisa Kits Product Portfolio
  6. 7.1.5 Thermo Fisher Scientific Recent Developments
  7. 7.2 MilliporeSigma (Merck KGaA)
  8. 7.2.1 MilliporeSigma (Merck KGaA) Company Information
  9. 7.2.2 MilliporeSigma (Merck KGaA) Business Overview
  10. 7.2.3 MilliporeSigma (Merck KGaA) Immunology-Oncology Elisa Kits Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 MilliporeSigma (Merck KGaA) Immunology-Oncology Elisa Kits Product Portfolio
  12. 7.2.5 MilliporeSigma (Merck KGaA) Recent Developments
  13. 7.3 RayBiotech Life, Inc.
  14. 7.3.1 RayBiotech Life, Inc. Company Information
  15. 7.3.2 RayBiotech Life, Inc. Business Overview
  16. 7.3.3 RayBiotech Life, Inc. Immunology-Oncology Elisa Kits Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 RayBiotech Life, Inc. Immunology-Oncology Elisa Kits Product Portfolio
  18. 7.3.5 RayBiotech Life, Inc. Recent Developments
  19. 7.4 Enzo Life Sciences
  20. 7.4.1 Enzo Life Sciences Company Information
  21. 7.4.2 Enzo Life Sciences Business Overview
  22. 7.4.3 Enzo Life Sciences Immunology-Oncology Elisa Kits Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Enzo Life Sciences Immunology-Oncology Elisa Kits Product Portfolio
  24. 7.4.5 Enzo Life Sciences Recent Developments
  25. 7.5 ELISAGEN Biotech
  26. 7.5.1 ELISAGEN Biotech Company Information
  27. 7.5.2 ELISAGEN Biotech Business Overview
  28. 7.5.3 ELISAGEN Biotech Immunology-Oncology Elisa Kits Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 ELISAGEN Biotech Immunology-Oncology Elisa Kits Product Portfolio
  30. 7.5.5 ELISAGEN Biotech Recent Developments
  31. 7.6 Creative Diagnostics
  32. 7.6.1 Creative Diagnostics Company Information
  33. 7.6.2 Creative Diagnostics Business Overview
  34. 7.6.3 Creative Diagnostics Immunology-Oncology Elisa Kits Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Creative Diagnostics Immunology-Oncology Elisa Kits Product Portfolio
  36. 7.6.5 Creative Diagnostics Recent Developments
  37. 7.7 Bio-Techne Corporation (R&D Systems)
  38. 7.7.1 Bio-Techne Corporation (R&D Systems) Company Information
  39. 7.7.2 Bio-Techne Corporation (R&D Systems) Business Overview
  40. 7.7.3 Bio-Techne Corporation (R&D Systems) Immunology-Oncology Elisa Kits Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Bio-Techne Corporation (R&D Systems) Immunology-Oncology Elisa Kits Product Portfolio
  42. 7.7.5 Bio-Techne Corporation (R&D Systems) Recent Developments
  43. 7.8 BioLegend (part of PerkinElmer)
  44. 7.8.1 BioLegend (part of PerkinElmer) Company Information
  45. 7.8.2 BioLegend (part of PerkinElmer) Business Overview
  46. 7.8.3 BioLegend (part of PerkinElmer) Immunology-Oncology Elisa Kits Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 BioLegend (part of PerkinElmer) Immunology-Oncology Elisa Kits Product Portfolio
  48. 7.8.5 BioLegend (part of PerkinElmer) Recent Developments
  49. 7.9 BD Biosciences
  50. 7.9.1 BD Biosciences Company Information
  51. 7.9.2 BD Biosciences Business Overview
  52. 7.9.3 BD Biosciences Immunology-Oncology Elisa Kits Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 BD Biosciences Immunology-Oncology Elisa Kits Product Portfolio
  54. 7.9.5 BD Biosciences Recent Developments
  55. 7.10 Abcam
  56. 7.10.1 Abcam Company Information
  57. 7.10.2 Abcam Business Overview
  58. 7.10.3 Abcam Immunology-Oncology Elisa Kits Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Abcam Immunology-Oncology Elisa Kits Product Portfolio
  60. 7.10.5 Abcam Recent Developments
8 North America
  1. 8.1 North America Immunology-Oncology Elisa Kits Market Size by Type
  2. 8.1.1 North America Immunology-Oncology Elisa Kits Revenue by Type (2021-2032)
  3. 8.1.2 North America Immunology-Oncology Elisa Kits Sales by Type (2021-2032)
  4. 8.1.3 North America Immunology-Oncology Elisa Kits Price by Type (2021-2032)
  5. 8.2 North America Immunology-Oncology Elisa Kits Market Size by Application
  6. 8.2.1 North America Immunology-Oncology Elisa Kits Revenue by Application (2021-2032)
  7. 8.2.2 North America Immunology-Oncology Elisa Kits Sales by Application (2021-2032)
  8. 8.2.3 North America Immunology-Oncology Elisa Kits Price by Application (2021-2032)
  9. 8.3 North America Immunology-Oncology Elisa Kits Market Size by Country
  10. 8.3.1 North America Immunology-Oncology Elisa Kits Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Immunology-Oncology Elisa Kits Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Immunology-Oncology Elisa Kits Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Immunology-Oncology Elisa Kits Market Size by Type
  2. 9.1.1 Europe Immunology-Oncology Elisa Kits Revenue by Type (2021-2032)
  3. 9.1.2 Europe Immunology-Oncology Elisa Kits Sales by Type (2021-2032)
  4. 9.1.3 Europe Immunology-Oncology Elisa Kits Price by Type (2021-2032)
  5. 9.2 Europe Immunology-Oncology Elisa Kits Market Size by Application
  6. 9.2.1 Europe Immunology-Oncology Elisa Kits Revenue by Application (2021-2032)
  7. 9.2.2 Europe Immunology-Oncology Elisa Kits Sales by Application (2021-2032)
  8. 9.2.3 Europe Immunology-Oncology Elisa Kits Price by Application (2021-2032)
  9. 9.3 Europe Immunology-Oncology Elisa Kits Market Size by Country
  10. 9.3.1 Europe Immunology-Oncology Elisa Kits Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Immunology-Oncology Elisa Kits Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Immunology-Oncology Elisa Kits Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Immunology-Oncology Elisa Kits Market Size by Type
  2. 10.1.1 China Immunology-Oncology Elisa Kits Revenue by Type (2021-2032)
  3. 10.1.2 China Immunology-Oncology Elisa Kits Sales by Type (2021-2032)
  4. 10.1.3 China Immunology-Oncology Elisa Kits Price by Type (2021-2032)
  5. 10.2 China Immunology-Oncology Elisa Kits Market Size by Application
  6. 10.2.1 China Immunology-Oncology Elisa Kits Revenue by Application (2021-2032)
  7. 10.2.2 China Immunology-Oncology Elisa Kits Sales by Application (2021-2032)
  8. 10.2.3 China Immunology-Oncology Elisa Kits Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Immunology-Oncology Elisa Kits Market Size by Type
  2. 11.1.1 Asia Immunology-Oncology Elisa Kits Revenue by Type (2021-2032)
  3. 11.1.2 Asia Immunology-Oncology Elisa Kits Sales by Type (2021-2032)
  4. 11.1.3 Asia Immunology-Oncology Elisa Kits Price by Type (2021-2032)
  5. 11.2 Asia Immunology-Oncology Elisa Kits Market Size by Application
  6. 11.2.1 Asia Immunology-Oncology Elisa Kits Revenue by Application (2021-2032)
  7. 11.2.2 Asia Immunology-Oncology Elisa Kits Sales by Application (2021-2032)
  8. 11.2.3 Asia Immunology-Oncology Elisa Kits Price by Application (2021-2032)
  9. 11.3 Asia Immunology-Oncology Elisa Kits Market Size by Country
  10. 11.3.1 Asia Immunology-Oncology Elisa Kits Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Immunology-Oncology Elisa Kits Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Immunology-Oncology Elisa Kits Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Immunology-Oncology Elisa Kits Market Size by Type
  2. 12.1.1 SAMEA Immunology-Oncology Elisa Kits Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Immunology-Oncology Elisa Kits Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Immunology-Oncology Elisa Kits Price by Type (2021-2032)
  5. 12.2 SAMEA Immunology-Oncology Elisa Kits Market Size by Application
  6. 12.2.1 SAMEA Immunology-Oncology Elisa Kits Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Immunology-Oncology Elisa Kits Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Immunology-Oncology Elisa Kits Price by Application (2021-2032)
  9. 12.3 SAMEA Immunology-Oncology Elisa Kits Market Size by Country
  10. 12.3.1 SAMEA Immunology-Oncology Elisa Kits Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Immunology-Oncology Elisa Kits Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Immunology-Oncology Elisa Kits Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Immunology-Oncology Elisa Kits Value Chain Analysis
  2. 13.1.1 Immunology-Oncology Elisa Kits Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Immunology-Oncology Elisa Kits Production Mode & Process
  6. 13.2 Immunology-Oncology Elisa Kits Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Immunology-Oncology Elisa Kits Distributors
  9. 13.2.3 Immunology-Oncology Elisa Kits Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research